Gianfranco Pagano

10.2k total citations · 4 hit papers
166 papers, 7.8k citations indexed

About

Gianfranco Pagano is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Gianfranco Pagano has authored 166 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Endocrinology, Diabetes and Metabolism, 47 papers in Surgery and 42 papers in Epidemiology. Recurrent topics in Gianfranco Pagano's work include Diabetes, Cardiovascular Risks, and Lipoproteins (46 papers), Diabetes Management and Research (27 papers) and Liver Disease Diagnosis and Treatment (26 papers). Gianfranco Pagano is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (46 papers), Diabetes Management and Research (27 papers) and Liver Disease Diagnosis and Treatment (26 papers). Gianfranco Pagano collaborates with scholars based in Italy, Belarus and New Zealand. Gianfranco Pagano's co-authors include Maurizio Cassader, Roberto Gambino, Giovanni Musso, P. Cavallo‐Perin, Simona Bo, Marilena Durazzo, Graziella Bruno, Giovanni Pacini, Franco Merletti and G Bargero and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and American Journal of Clinical Nutrition.

In The Last Decade

Gianfranco Pagano

164 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

2010 1.0k citations Giovanni Musso, Roberto Gambino et al. Annals of Medicine profile →
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association

2002 626 citations Gianfranco Pagano, Giovanni Pacini et al. Hepatology profile →
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

2005 590 citations Roberto Gambino, Maurizio Cassader et al. Diabetologia profile →
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease

2010 437 citations Giovanni Musso, Roberto Gambino et al. Hepatology profile →

Peers

Gianfranco Pagano

EPIDE

EDM

SURGE

PHYSI

MB

Gabriele Forlani Italy

Bong Soo South Korea

Byung‐Wan Lee South Korea

Bruno Vergès France

Roberto Testa Italy

Asterios Karagiannis Greece

P. Cavallo‐Perin Italy

Nazario Melchionda Italy

Vasilios G. Athyros Greece

Ferdinando Carlo Sasso Italy

Gabriele Forlani Italy

Gianfranco Pagano

5.5k ×1.4

EPIDE

3.5k ×0.9

EDM

1.1k ×0.7

SURGE

1.2k ×1.0

PHYSI

1.1k ×0.9

MB

Citations per year, relative to Gianfranco Pagano Gianfranco Pagano (= 1×) peers Gabriele Forlani

Countries citing papers authored by Gianfranco Pagano

Since Specialization

Citations

This map shows the geographic impact of Gianfranco Pagano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianfranco Pagano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianfranco Pagano more than expected).

Fields of papers citing papers by Gianfranco Pagano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianfranco Pagano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianfranco Pagano. The network helps show where Gianfranco Pagano may publish in the future.

Co-authorship network of co-authors of Gianfranco Pagano

This figure shows the co-authorship network connecting the top 25 collaborators of Gianfranco Pagano. A scholar is included among the top collaborators of Gianfranco Pagano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianfranco Pagano. Gianfranco Pagano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Musso, Giovanni, Roberto Gambino, Franco De Michieli, et al.. (2008). Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis. Annals of Medicine. 40(5). 383–394. 15 indexed citations

2.

Musso, Giovanni, Roberto Gambino, Giovanni Pacini, et al.. (2008). Transcription factor 7–like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH #. Hepatology. 49(2). 426–435. 73 indexed citations

3.

Bo, Simona, Roberto Gambino, Marilena Durazzo, et al.. (2008). Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction. Journal of Endocrinological Investigation. 31(6). 499–504. 30 indexed citations

4.

Bo, Simona, Marilena Durazzo, Carlotta Sacerdote, et al.. (2006). Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. American Journal of Clinical Nutrition. 84(5). 1062–1069. 122 indexed citations

5.

Musso, Giovanni, Roberto Gambino, Marilena Durazzo, et al.. (2005). Adipokines in NASH: Postprandial Lipid Metabolism as a Link Between Adiponectin and Liver Disease *. Hepatology. 42(5). 1175–1183. 228 indexed citations

6.

Bo, Simona, Guido Menato, C Bardelli, et al.. (2004). Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstetricia Et Gynecologica Scandinavica. 83(4). 335–340. 7 indexed citations

7.

Bo, Simona, Guido Menato, C Bardelli, et al.. (2004). Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstetricia Et Gynecologica Scandinavica. 83(4). 335–340. 45 indexed citations

8.

Brizzi, Maria Felice, Patrizia Dentelli, Arturo Rosso, et al.. (2004). RAGE and TGF beta receptor-mediated signals converge on STAT5 and p21(WAF) to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy.. Diabetologia. 47. 17 indexed citations

9.

Bruno, Graziella, Sara Giunti, G Bargero, et al.. (2004). Sex‐differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: The Casale Monferrato Study. Diabetic Medicine. 21(8). 823–828. 21 indexed citations

10.

Bo, Simona, P. Cavallo‐Perin, Luigi Gentile, Elena Repetti, & Gianfranco Pagano. (2001). Low HDL-cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients.. PubMed. 27(1). 31–5. 10 indexed citations

11.

Gambino, Roberto, et al.. (1999). Apolipoprotein H Is Not Affected by In Vitro Glycosylation. Journal of Protein Chemistry. 18(2). 173–177. 1 indexed citations

12.

Gruden, Gabriella, P. Cavallo‐Perin, C. Olivetti, et al.. (1995). Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. Diabetologia. 38(10). 1218–1222. 19 indexed citations

13.

Gruden, Gabriella, et al.. (1995). Thrombomodulin Levels in Insulin‐dependent Diabetic Patients with Microalbuminuria. Diabetic Medicine. 12(3). 258–260. 10 indexed citations

14.

Cassader, Maurizio, Roberto Gambino, Antonio Pagano, et al.. (1994). Influence of apolipoprotein H polymorphism on levels of triglycerides. Atherosclerosis. 110(1). 45–51. 37 indexed citations

15.

Cavallo‐Perin, P., et al.. (1991). The increase in albuminuria induced by exercise is not associated with preferential excretion of glycated albumin in Type 1 (insulin-dependent) diabetic patients. Diabetologia. 34(11). 813–816. 1 indexed citations

16.

Cavallo‐Perin, P., et al.. (1991). Benfluorex and blood glucose control in non insulin-dependent diabetic patients. Journal of Endocrinological Investigation. 14(2). 109–113. 6 indexed citations

17.

Cassader, Maurizio, et al.. (1991). Lipoprotein-apolipoprotein changes in renal transplant recipients: A 2-year follow-up. Metabolism. 40(9). 922–925. 14 indexed citations

18.

Cassader, Maurizio, et al.. (1989). Lipoprotein and apoprotein levels in different types of dialysis. The International Journal of Artificial Organs. 12(7). 433–438. 5 indexed citations

19.

Cavallo‐Perin, P., et al.. (1989). Electrical anionic charges on red blood cells are reduced in insulin-dependent diabetic patients. Journal of Diabetic Complications. 3(1). 45–48. 2 indexed citations

20.

Pagano, Gianfranco, et al.. (1986). Comparison of Acarbose and Phenformin treatment in Glibenclamide-treated non-insulin dependent diabetics.. Current Therapeutic Research. 39(1). 143–148. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact